Scott Wolchko | President and Chief Executive Officer |
Wayne Chu | Chief Medical Officer |
Ed Dulac | Chief Financial Officer |
Bob Valamehr | Chief Research and Development Officer |
Carly Kenselaar | Citi |
Daina Graybosch | SVB Securities |
Tazeen Ahmad | Bank of America |
Andrea Tan | Goldman Sachs |
Robyn Karnauskas | Truist |
Mara Goldstein | Mizuho |
Matthew Biegler | Oppenheimer |
Welcome to the Fate Therapeutics Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate’s website at fatetherapeutics.com.
As a reminder, today’s call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.